In a move to expand its portfolio of medical technologies, contract manufacturer of Nitinol-based and balloon catheter medical devices, Confluent Medical Technologies has acquired ETE Medical and its operating subsidiaries Biomedical Structures (BMS) and Modified Polymer Components (MPC).

Following the transaction, the combined company will offer complementary, best-of-class technologies to provide high-quality, cost-effective medical device contract manufacturing, testing and design services to its customers.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Nissha Medical International, a wholly-owned subsidiary of Nissha Printing, a manufacturer of industrial materials and electronic components, intends to acquire Graphic Controls Holdings from WestView Capital Partners, a private equity firm, and others, for approximately $135m.

"The acquisition will provide the acquirer with an opportunity to venture into medical devices and contract manufacturing businesses."

Following the transaction, which will be closed in August 2016, Graphic Controls, its subsidiary Graphic Controls Acquisition, and its related group companies will become subsidiaries of Nissha Printing.

The acquisition will provide the acquirer with an opportunity to venture into medical devices and contract manufacturing businesses.

See Also:

Assurex Health has been acquired by Myriad Merger Sub, a wholly-owned subsidiary of molecular diagnostic company, Myriad Genetics. The acquisition will enable Myriad to expand its portfolio and strengthen its position in psychotropic drugs business.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The $410m deal is planned to be funded through cash on hand and possibly short-term debt.

Pursuant to the agreement, which is expected to close before the end of Q1 2017, Myriad Merger Sub will be merged with and into Assurex, while the latter will become a wholly-owned subsidiary of Myriad.